Precision Psychiatry Market Size Worth USD 3,254.83 Million by 2034 | CAGR: 14.5%
The precision psychiatry market size is expected to reach USD 3,254.83 Million by 2034, according to a new study by Polaris Market Research. The report “Precision Psychiatry Market Share, Size, Trends, Industry Analysis Report: By Product Type, By Sample, By Biomarker Type, By Technology, By Application, By End User, and By Region; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Global precision psychiatry market is also driven by instruments and solutions to detect biomarkers and genetic signatures associated with psychiatric diseases which supports focused diagnosis and customized treatment in pharmaceutical and clinical research domain. The growth of market can be attributed to increasing awareness about mental health, growing neurogenomic research and rising adoption of AI based diagnostic tools leading to improved precision of treatment and clinical outcomes.
Precision Psychiatry Market Report Highlights
- By product type, the products segment held the largest share in 2024, owing to the growing application of genomic and biomarker testing instrument in clinical and research field.
- On the basis of the sample, the blood-based segment accounted for the major share in 2024 as a result of its trustworthiness and noninvasive property to detect biomarkers.
- Based on biomarker, the genetic biomarker segment held the largest market in 2024, owing to escalating research on psychiatric gene variants and heritable risk factors.
- By technology, the sequencing segment held the highest market share in 2024 attributed to increasing utilization of next generation sequencing in the analysis of neurogenomics.
- By application, the depression segment will grow at fastest rate, owing to rising genomics research and AI-driven diagnostics.
- Based on end user, the hospitals and diagnostic laboratories accounted for largest share in 2024, attributable to the growing number of patients and rising adoption of genomic testing.
- North America held the largest market share in 2024 owing to well-developed mental health research infrastructure and sophisticated AI-enabled diagnostics.
- The fastest growth is expected to be seen in the Asia Pacific region from 2025 to 2034 due to increasing funding for genomic research and mental health awareness.
- Key players in the global market include Boehringer Ingelheim International GmbH, Alto Neuroscience Inc., Altimate Healthcare, Feel Therapeutics, Tempus, HMNC Holding GmbH, Spring Care, Inc., Mobio Interactive, NeuroKaire, Illumina, Inc., Otsuka Precision Health, Inc., Genomind, and Atai Life Sciences N.V.
Request a free sample copy or read the full market insights : precision psychiatry market Report
Polaris Market Research has segmented the market report based on product type, sample, biomarker type, technology, application, end user, and region:
By Product Type Outlook (Revenue, USD Million, 2020–2034)
- Products
- Services
By Sample Outlook (Revenue, USD Million, 2020–2034)
- Blood-Based
- Non-Blood-Based
- Saliva
- Urine
- Cerebral Spinal Fluid (CSF)
- Others
By Biomarker Type Outlook (Revenue, USD Million, 2020–2034)
- Genetic Biomarker
- Protein Biomarker
By Technology Outlook (Revenue, USD Million, 2020–2034)
- Sequencing
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Polymerase Chain Reaction (PCR)
- Real-Time Polymerase Chain Reaction (RT-PCR)
- Digital Polymerase Chain Reaction (dPCR)
- Microarray
- Immunoassay
- Liquid Chromatography-Mass Spectrometry (LC-MS)
- Others
By Application Outlook (Revenue, USD Million, 2020–2034)
- Alzheimer’s Disease
- Parkinson’s Disease
- Autism
- Depression
- Bipolar Disease
- Others
By End User Outlook (Revenue, USD Million, 2020–2034)
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutions
- Others
By Regional Outlook (Revenue, USD Million, 2020–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Vietnam
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
